The current report is an update of the reports on Legislation on biotechnology in the Nordic countries published annually since 2014. Given the clear need for such overviews, the Nordic Committee on Bioethics decided to update the tables to reflect recent legal amendments.
The aim of this report is to give the reader information on the current status in the different countries and a chance to compare the legal situation. In this edition we have added two new topics. One is NIPT (Non-Invasive Prenatal Test).
The other is Direct-to-consumer genetic testing (DTC-GT). DTC-GT was introduced to the private market without any formal procedures and remains to a large degree unregulated. As part of the national health care systems, the use of NIPT requires a formal process of approval, carried out either by the government or hospital. But also NIPT is offered as a private service.